Lilly Asia Ventures
Founded in 2008, Lilly Asia Ventures is a corporate venture capital arm of Eli Lilly headquartered in Hongkong. The firm prefers to invest in seed-stage, early-stage, and later-stage companies. The firm seeks to invest in healthcare, life sciences, manufacturing, the internet of things, oncology, and technology-based sectors in China and the United States.
Total Investments
307
Portfolio Companies
8
Exits
0
Funds
0
Investment Activity
Recent deal flow and investment pace
Last 6 Months
4
deals
Last 12 Months
14
deals
Last 2 Years
31
deals
Notable Portfolio Companies
Recent and prominent investments
Investment Focus
AUM
$5.6B